Source: International Congress 2017 – MDRTB: detection and management
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
N. KOBAYASHI (Kiyose, Tokyo, Japan). Treatment outcomes in patients with multidrug-resistant tuberculosis in Japan, 2011-2013. 3494

Member's Comments

No comment yet.

Related content which might interest you: Treatment outcome of multidrug/extensively drug-resistant tuberculosis in Latvia, 2000-2004 Source: Eur Respir J 2010; 36: 584-593 Year: 2010 Treatment outcome of XDR-TB patients in Iran during 2003-2006 Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis Year: 2008 Our experience and treatment results of multidrug-resistant tuberculosis (MDR-TB) patients between 1996-2002 Source: Eur Respir J 2003; 22: Suppl. 45, 42s Year: 2003 Treatment outcomes of MDR-TB patients notified in Romania during 2005-2007 Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis Year: 2011 Treatment outcomes and deaths among multidrug-resistant tuberculosis (MDR-TB) patients in Gomel region, Belarus – 2009-2010 Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights Year: 2013 Management of MDR and rifampicin-resistant TB cases in Italy, 1995-1999 Source: Eur Respir J 2001; 18: Suppl. 33, 513s Year: 2001 Characteristics of XDR-TB patients in Israel: 2000-2010 Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis Year: 2011 Treatment outcome in multidrug resistant tuberculosis cases at our clinic between 1996-2008 Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis Year: 2009 Treatment outcome and factors associated with unfavourable treatment results in cases with multidrug-resistant tuberculosis in Bulgaria for the period 2009-2010 Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences Year: 2012 Treatment of tuberculosis in Hungary in 2003 Source: Eur Respir J 2004; 24: Suppl. 48, 652s Year: 2004 Trend and risk factors of drug resistance tuberculosis between 2005-2012 in Istanbul, Turkey Source: International Congress 2015 – Management of TB: a patient focus Year: 2015 High proportion of fluoroquinolone mono-resistant mycobacterium tuberculosis (MTB) strains in Pakistan (2010-2012) Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Multidrug–resistant tuberculosis in Czech Republic during the period of recent 5 years (2007-2012) Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II Year: 2013 Treatment outcomes of smear-positive pulmonary TB cases in Romania in 2006-2008 Source: Annual Congress 2010 - Prognosis of tuberculosis Year: 2010 Epidemiology of tuberculosis (TB) in Poland in the period 1994-2003 Source: Eur Respir J 2005; 26: Suppl. 49, 191s Year: 2005 Characteristics of patients under treatment for NTM disease during the period 2004-2013 in Greece Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2 Year: 2014 The epidemiological characteristics of tuberculosis (TB) in Romania between 2000-2008 Source: Annual Congress 2010 - Tuberculosis epidemiology Year: 2010 Mortality and associated factors among drug-resistant tuberculosis patients in Portugal, 2000-2016 Source: Virtual Congress 2020 – Tuberculosis: part 2 Year: 2020 Drug resistance of mycobacterium tuberculosis isolates in Serbia over five-year period (2001-2005) Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis Year: 2008 Treatment outcomes of MDR-TB cases registered in Bucharest sector 4 during 2004-2008 Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences Year: 2012